Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Octopus Biosafety Total Payout Ratio Related Terms
Octopus Biosafety Total Payout Ratio Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Total Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OCR vs DELL, ANET, SNDK: Total Payout Ratio Comparison
For the Computer Hardware subindustry, Octopus Biosafety's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Total Payout Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Total Payout Ratio distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Total Payout Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (STU:OCR) has a Total Payout Ratio of 0.00 as of Aug. 20, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Total Payout Ratio too high?
Octopus Biosafety's current Total Payout Ratio is 0.00. Overall, Octopus Biosafety has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Total Payout Ratio compare to DELL and ANET?
Octopus Biosafety's Total Payout Ratio of 0.00 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Hardware company?
A good Total Payout Ratio depends on the Hardware industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Total Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Total Payout Ratio of 0.00. The stock's GF Value™ is €0.08, compared to a current price of €0.05 — trading 37.5% below its estimated fair value. The current Total Payout Ratio is 0.00. Octopus Biosafety's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Total Payout Ratio is 0.00 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be undervalued.
The current stock price of €0.05 is trading 37.5% below its estimated GF Value™ of €0.08.
Key valuation signals for STU:OCR:
Total Payout Ratio: 0.00
GF Value™: €0.08 vs. price of €0.05 (37.5% below fair value)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
8GF Score
Get the complete analysis for STU:OCR
Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
